Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Doxorubicin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 39 Breast Neoplasms 27 Lymphoma 24 Sarcoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Hodgkin Disease 20 Burkitt Lymphoma 20 Triple Negative Breast Neoplasms 18 Lymphoma, Follicular 14 Lymphoma, B-Cell 13 Ovarian Neoplasms 11 Neoplasms 10 Lymphoma, Non-Hodgkin 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 8 Lymphoma, Mantle-Cell 8 Endometrial Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, B-Cell, Marginal Zone 6 Liposarcoma 6 Leukemia 6 Recurrence 5 Osteosarcoma 5 Neuroblastoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leiomyosarcoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma, Ewing 4

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡